Alkermes falls 8.8% despite alixorexton hitting key goals in a narcolepsy type 1 study, as cataplexy data stirs investor concerns.

Explore how control and data buses enable seamless transmission and timely, synchronised imaging for high-performance ...

Climate-smart farming: How satellites and data are helping farmers respond to uncertainty What is needed is wider reach, ongoing support and policies that reward sustainable practices ...

FURVENT is a global, pivotal 3 arm Phase 3 clinical trial of firmonertinib in first-line non-squamous locally advanced or metastatic NSCLC patients with exon 20 insertion mutations being conducted ...

MNRE tightens cybersecurity for rooftop solar plants under PMSG: MBY to ensure grid stability and data protection.

Allianz Life Insurance Company of North America said it suffered a system breach on July 16 that affected a majority of its 1.4 million customers.

AstraZeneca’s top-selling drug Tagrisso is already widely used on its own as a first-line treatment for EGFR-mutated lung cancer, but new data suggests there can be benefits from combining it ...

The speculation over whether the BJP will support a TDP candidate in the upcoming Jubilee Hills by-poll signals a broader realignment in Telangana’s political landscape. The 2023 Assembly ...

Takeda has reported updated results from its ALTA-1L trial of Alunbrig (brigatinib) versus Xalkori (crizotinib) in first-line treatment of AK-positive non-small cell lung cancer (NSCLC), saying ...

Expert clarifies concerning data about global trend: 'The further that red line goes up, the faster this change will happen' first appeared on The Cool Down.